The anti-inflammatory agent colchicine — used mostly in the treatment of gout — appears to be effective for treating acute pericarditis and in preventing recurrences of the condition,… read more.
Some of the most important studies presented at ESC Congress 2013, included : HOKUSAI-VTE: The oral anticoagulant edoxaban for the treatment of venous thromboembolism (VTE) resulted in equal… read more.
Among patients with non-ST-segment elevation acute coronary syndrome (ACS), pretreatment with prasugrel before angiography did not improve outcomes and worsened bleeding, a randomized trial showed.
Study presenter Deepak Bhatt (pictured) – The anti-hyperglycemic agent saxagliptin neither increased or decreased therate of ischemic events when added to standard of care in patients with type… read more.
By Bruce Sylvester – In a 3-decade study of adults recruited in the United States, researchers report positive correlations between durations of overall obesity and abdominal obesity and… read more.
Breaking a sweat while working out regularly may reduce your risk of stroke, according to new research in the American Heart Association journal Stroke.
New research from a study of over 73,000 patients. People with high blood pressure, who don’t take their anti-hypertensive drug treatments when they should, have a greatly increased… read more.
Taken from JAMA – by Bruce Sylvester – After analyzing data on nearly 60,000 patients with acute ischemic stroke, researchers report that thrombolytic treatment initiated sooner correlates to… read more.
Taken from the Lancet – by Bruce Sylvester – High doses of some non-steroidal anti-inflammatory drugs (NSAIDs) increase the risk of major vascular events (non-fatal heart attacks, strokes,… read more.
FDA Highlights by Bruce Sylvester – Lexapro (escitalopram), which is used to treat depression and anxiety, appears to improve a stress-related heart condition in persons with stable coronary… read more.
Trend toward more cancers and more deaths among heart failure patients. Heart failure patients are surviving more often with the heart condition but they are increasingly more likely… read more.
Could cut costs of aftercare – The latest results from the third International Stroke Trial (IST-3) suggest that the drug has the potential to cut costs by reducing… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
